GLP1R imaging was successfully performed to detect insulinomas in human patients by using radionuclide-labeled exendin-4, an analogue of the metabolically unstable endogenous ligand glucagon-like peptide-1 (GLP1) (11). This evidence concerns the gene GCG and pancreatic insulinoma.